Canaccord Genuity Upgrades RTI Biologics (RTIX) to Buy
Tweet
Share
E-mailGet Alerts RTIX Hot Sheet
Price: $3.14 --0%
Rating Summary:
5 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 10 | New: 48
Rating Summary:
5 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 10 | New: 48
Join SI Premium – FREE
Canaccord Genuity upgraded RTI Biologics (NASDAQ: RTIX) from Hold to Buy with a price target of $5.00.
For an analyst ratings summary and ratings history on RTI Biologics click here. For more ratings news on RTI Biologics click here.
Shares of RTI Biologics closed at $3.93 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cantor Fitzgerald Upgrades Omeros Corp. (OMER) to Overweight, 'We May Have Underestimated Yartemlea'
- Kepler Cheuvreux Upgrades OC Oerlikon Corp AG (OERL:SW) (OERLF) to Buy
- Oura seeks to raise up to $2.2 billion in Nasdaq IPO
Create E-mail Alert Related Categories
UpgradesRelated Entities
Canaccord GenuitySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
